Financhill
Sell
40

MTD Quote, Financials, Valuation and Earnings

Last price:
$1,201.60
Seasonality move :
5.76%
Day range:
$1,200.10 - $1,226.44
52-week range:
$1,142.91 - $1,546.93
Dividend yield:
0%
P/E ratio:
29.66x
P/S ratio:
6.62x
P/B ratio:
--
Volume:
129.6K
Avg. volume:
156.6K
1-year change:
-7.94%
Market cap:
$25.1B
Revenue:
$3.9B
EPS (TTM):
$40.53

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MTD
Mettler-Toledo International
$1B $11.72 -5.42% -4.25% $1,366.60
CTSO
CytoSorbents
$10.1M -$0.07 12.22% -41.38% $5.00
DCTH
Delcath Systems
$15M $0.01 436.11% -93.78% $22.50
DGX
Quest Diagnostics
$2.6B $2.18 11.83% 28.2% $176.97
EXAS
Exact Sciences
$701.5M -$0.19 8.3% -83.75% $69.43
STRR
Star Equity Holdings
$17.1M -$0.17 21.89% -67.63% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MTD
Mettler-Toledo International
$1,201.99 $1,366.60 $25.1B 29.66x $0.00 0% 6.62x
CTSO
CytoSorbents
$1.07 $5.00 $58.8M -- $0.00 0% 1.67x
DCTH
Delcath Systems
$12.08 $22.50 $403.5M -- $0.00 0% 9.55x
DGX
Quest Diagnostics
$168.82 $176.97 $18.7B 21.95x $0.75 1.78% 1.94x
EXAS
Exact Sciences
$43.04 $69.43 $8B -- $0.00 0% 2.87x
STRR
Star Equity Holdings
$2.15 -- $6.9M 0.75x $0.00 0% 0.14x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MTD
Mettler-Toledo International
106.72% 1.575 7.86% 0.64x
CTSO
CytoSorbents
51.51% 1.525 16.8% 1.46x
DCTH
Delcath Systems
-- 2.016 -- 10.46x
DGX
Quest Diagnostics
48.48% 0.412 38.46% 0.85x
EXAS
Exact Sciences
51.69% 0.862 24.64% 1.76x
STRR
Star Equity Holdings
15.99% -0.471 31.89% 1.35x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MTD
Mettler-Toledo International
$639.3M $333.7M 45.08% -- 31.81% $224.9M
CTSO
CytoSorbents
$4.5M -$4.4M -70.49% -103.21% -20.27% -$2.8M
DCTH
Delcath Systems
$13M $3M -97.08% -117.89% 68.93% -$1.2M
DGX
Quest Diagnostics
$858M $361M 7.24% 12.99% 14.16% $341M
EXAS
Exact Sciences
$429.2M -$38.1M -18.69% -34.11% -121.63% $10.7M
STRR
Star Equity Holdings
$2.8M -$5.3M -9.23% -10.13% -38.95% $420K

Mettler-Toledo International vs. Competitors

  • Which has Higher Returns MTD or CTSO?

    CytoSorbents has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -27.1%. Mettler-Toledo International's return on equity of -- beat CytoSorbents's return on equity of -103.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    CTSO
    CytoSorbents
    52.3% -$0.04 $26.8M
  • What do Analysts Say About MTD or CTSO?

    Mettler-Toledo International has a consensus price target of $1,366.60, signalling upside risk potential of 13.69%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 367.29%. Given that CytoSorbents has higher upside potential than Mettler-Toledo International, analysts believe CytoSorbents is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    CTSO
    CytoSorbents
    1 1 0
  • Is MTD or CTSO More Risky?

    Mettler-Toledo International has a beta of 1.151, which suggesting that the stock is 15.088% more volatile than S&P 500. In comparison CytoSorbents has a beta of 0.779, suggesting its less volatile than the S&P 500 by 22.149%.

  • Which is a Better Dividend Stock MTD or CTSO?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or CTSO?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than CytoSorbents quarterly revenues of $8.6M. Mettler-Toledo International's net income of $252.3M is higher than CytoSorbents's net income of -$2.3M. Notably, Mettler-Toledo International's price-to-earnings ratio is 29.66x while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.62x versus 1.67x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.62x 29.66x $1B $252.3M
    CTSO
    CytoSorbents
    1.67x -- $8.6M -$2.3M
  • Which has Higher Returns MTD or DCTH?

    Delcath Systems has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -22.5%. Mettler-Toledo International's return on equity of -- beat Delcath Systems's return on equity of -117.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DCTH
    Delcath Systems
    85.92% -$0.11 $68.7M
  • What do Analysts Say About MTD or DCTH?

    Mettler-Toledo International has a consensus price target of $1,366.60, signalling upside risk potential of 13.69%. On the other hand Delcath Systems has an analysts' consensus of $22.50 which suggests that it could grow by 86.26%. Given that Delcath Systems has higher upside potential than Mettler-Toledo International, analysts believe Delcath Systems is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    DCTH
    Delcath Systems
    4 0 0
  • Is MTD or DCTH More Risky?

    Mettler-Toledo International has a beta of 1.151, which suggesting that the stock is 15.088% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.820, suggesting its less volatile than the S&P 500 by 17.957%.

  • Which is a Better Dividend Stock MTD or DCTH?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or DCTH?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Delcath Systems quarterly revenues of $15.1M. Mettler-Toledo International's net income of $252.3M is higher than Delcath Systems's net income of -$3.4M. Notably, Mettler-Toledo International's price-to-earnings ratio is 29.66x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.62x versus 9.55x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.62x 29.66x $1B $252.3M
    DCTH
    Delcath Systems
    9.55x -- $15.1M -$3.4M
  • Which has Higher Returns MTD or DGX?

    Quest Diagnostics has a net margin of 24.14% compared to Mettler-Toledo International's net margin of 8.47%. Mettler-Toledo International's return on equity of -- beat Quest Diagnostics's return on equity of 12.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DGX
    Quest Diagnostics
    32.74% $1.95 $13.3B
  • What do Analysts Say About MTD or DGX?

    Mettler-Toledo International has a consensus price target of $1,366.60, signalling upside risk potential of 13.69%. On the other hand Quest Diagnostics has an analysts' consensus of $176.97 which suggests that it could grow by 4.83%. Given that Mettler-Toledo International has higher upside potential than Quest Diagnostics, analysts believe Mettler-Toledo International is more attractive than Quest Diagnostics.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    DGX
    Quest Diagnostics
    7 10 0
  • Is MTD or DGX More Risky?

    Mettler-Toledo International has a beta of 1.151, which suggesting that the stock is 15.088% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.924, suggesting its less volatile than the S&P 500 by 7.577%.

  • Which is a Better Dividend Stock MTD or DGX?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.78% to investors and pays a quarterly dividend of $0.75 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Quest Diagnostics pays out 38% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MTD or DGX?

    Mettler-Toledo International quarterly revenues are $1B, which are smaller than Quest Diagnostics quarterly revenues of $2.6B. Mettler-Toledo International's net income of $252.3M is higher than Quest Diagnostics's net income of $222M. Notably, Mettler-Toledo International's price-to-earnings ratio is 29.66x while Quest Diagnostics's PE ratio is 21.95x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.62x versus 1.94x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.62x 29.66x $1B $252.3M
    DGX
    Quest Diagnostics
    1.94x 21.95x $2.6B $222M
  • Which has Higher Returns MTD or EXAS?

    Exact Sciences has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -121.19%. Mettler-Toledo International's return on equity of -- beat Exact Sciences's return on equity of -34.11%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    EXAS
    Exact Sciences
    60.16% -$4.67 $5B
  • What do Analysts Say About MTD or EXAS?

    Mettler-Toledo International has a consensus price target of $1,366.60, signalling upside risk potential of 13.69%. On the other hand Exact Sciences has an analysts' consensus of $69.43 which suggests that it could grow by 61.31%. Given that Exact Sciences has higher upside potential than Mettler-Toledo International, analysts believe Exact Sciences is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    EXAS
    Exact Sciences
    17 3 0
  • Is MTD or EXAS More Risky?

    Mettler-Toledo International has a beta of 1.151, which suggesting that the stock is 15.088% more volatile than S&P 500. In comparison Exact Sciences has a beta of 1.248, suggesting its more volatile than the S&P 500 by 24.844%.

  • Which is a Better Dividend Stock MTD or EXAS?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Exact Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Exact Sciences pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or EXAS?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Exact Sciences quarterly revenues of $713.4M. Mettler-Toledo International's net income of $252.3M is higher than Exact Sciences's net income of -$864.6M. Notably, Mettler-Toledo International's price-to-earnings ratio is 29.66x while Exact Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.62x versus 2.87x for Exact Sciences. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.62x 29.66x $1B $252.3M
    EXAS
    Exact Sciences
    2.87x -- $713.4M -$864.6M
  • Which has Higher Returns MTD or STRR?

    Star Equity Holdings has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -14.42%. Mettler-Toledo International's return on equity of -- beat Star Equity Holdings's return on equity of -10.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    STRR
    Star Equity Holdings
    20.62% -$0.78 $69.5M
  • What do Analysts Say About MTD or STRR?

    Mettler-Toledo International has a consensus price target of $1,366.60, signalling upside risk potential of 13.69%. On the other hand Star Equity Holdings has an analysts' consensus of -- which suggests that it could grow by 365.12%. Given that Star Equity Holdings has higher upside potential than Mettler-Toledo International, analysts believe Star Equity Holdings is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    STRR
    Star Equity Holdings
    1 0 0
  • Is MTD or STRR More Risky?

    Mettler-Toledo International has a beta of 1.151, which suggesting that the stock is 15.088% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.075, suggesting its less volatile than the S&P 500 by 92.536%.

  • Which is a Better Dividend Stock MTD or STRR?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Star Equity Holdings pays out 7.62% of its earnings as a dividend. Star Equity Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MTD or STRR?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Star Equity Holdings quarterly revenues of $13.7M. Mettler-Toledo International's net income of $252.3M is higher than Star Equity Holdings's net income of -$2M. Notably, Mettler-Toledo International's price-to-earnings ratio is 29.66x while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.62x versus 0.14x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.62x 29.66x $1B $252.3M
    STRR
    Star Equity Holdings
    0.14x 0.75x $13.7M -$2M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

3 Safest Stocks to Buy Now
3 Safest Stocks to Buy Now

With the S&P 500 now in correction and stocks selling…

Tesla Stock: The Bear Case
Tesla Stock: The Bear Case

The recent stock market drop has been a punishing time…

Is VUG a Good ETF to Buy?
Is VUG a Good ETF to Buy?

For the last few years, earnings growth from the tech…

Stock Ideas

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Alerts

Sell
5
CABO alert for Mar 14

Cable One [CABO] is down 14.08% over the past day.

Sell
38
ADBE alert for Mar 14

Adobe [ADBE] is down 13.89% over the past day.

Sell
29
CAR alert for Mar 14

Avis Budget Group [CAR] is down 11.48% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock